Firalis SAS

Biotechnologie | 15 followers

1 avis
  • Firalis SAS
    Firalis SAS
    3y ago

    Firalis s’est vu attribuer le 6e prix du Deloitte In Extenso Technology Fast 50 qui récompense les entreprises technologiques à forte croissance. Ce palmarès est réalisé en fonction du taux de croissance du chiffre d'affaires sur les quatre dernières années, durant lesquelles Firalis a connu un taux de croissance de 539 %. Pour plus d'informations rendez-vous sur http://www.firalis.com/?p=3337

  • Firalis SAS
    Firalis SAS
    3y ago
    Firalis recrute: Nous sommes en pleine expansion de l'activité commerciale (prestations de services et kits). Pour cela nous cherchons à recruter des personnes motivés pour rejoindre notre département commercial. Profil recherché: ESSENTIAL JOB FUNCTIONS o Prospect for potential new clients o Presentation & client interactions o Generate proposals, presentations, and participate to marketing strategies o Attend congresses and networking events MINIMUM REQUIREMENTS o Ability to work independently and in a team environment o Excellent communication and interpersonal skills o Scientific skills in biology (e.g. proteomics, genomics, metabolomics, flow cytometry) o Fluent in French and English, another language would be an asset o Familiarity with QMS (quality management systems) would be a plus
  • Firalis SAS
    Firalis SAS
    4y ago
    HTG Molecular Diagnostics and Firalis Announce Agreement to Develop a Theranostic Tool to Predict Response to Anti TNFα Therapies for Rheumatoid Arthritis HTG Molecular Diagnostics, Inc., a provider of instruments and reagents for molecular profiling applications, and Firalis S.A., a provider of bioanalytical services and biomarker-based products to biopharma, to biotechnology companies, and to academia, today announced an agreement to develop a next generation sequencing (NGS)-based theranostic tool to identify likely non-responders from responders to anti TNFα therapy for rheumatoid arthritis (RA).
  • Firalis SAS
    Firalis SAS
    4y ago
    Le 25 mai 2016, la biobanque de Firalis a été certifiée NF S 96-900 (norme qui définit les prescriptions générales en termes de systèmes de management de la qualité des centres de ressources biologiques (CRB)) en répondant aux exigences réglementaires en termes de qualité, de sécurité, de traçabilité et d'éthique. Créée en 2014, la biobanque a pour mission d’organiser la conservation des collections d'échantillons biologiques (sang, cellules, tissus ...), obtenus à partir de leurs propres recherches et collaborations. Avec une capacité de plus de 2 millions d’échantillons, Firalis propose une solution dédiée à la gestion et la surveillance des ressources biologiques pour l'industrie pharmaceutique et les organismes de recherche, en veillant à la qualité et au stockage à long terme des échantillons biologiques. Les installations de stockage, conformes aux normes réglementaires, sont exploitées par un personnel compétent et dans le respect des règles éthiques.
  • Firalis SAS
    Firalis SAS
    4y ago
    Meet us at ASCO Annual Meeting 2016 in Chicago from June 2-4 to find the right partner for your oncology biomarker research The Annual Meeting brings together 30,000 oncology professionals from around the world. Educational sessions feature world-renowned faculty discussing state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field. Science sessions present the latest ground-breaking research in oral and poster format. The theme of the upcoming ASCO Annual Meeting is "Collective Wisdom: The Future of Patient-Centered Care and Research." Join us for ASCO Annual Meeting at the McCormick Place in Chicago, June 2-4 2016 to explore opportunities to establish new collaborations.
  • Firalis SAS
    Firalis SAS
    4y ago
    Looking for a partner to enhance your biomarker research? Join us at the French Pavilion booth 705 at BIO 2016 The BIO International Convention (BIO) attracts over 15,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. This event covers a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy. Join us for BIO International Convention at the Moscone Center in San Francisco, June 6-9 2016 to explore opportunities to establish new collaborations.
  • Firalis SAS
    Firalis SAS
    4y ago

    Firalis SAS at Arab Health 2016 Where the Future of Healthcare is on Display Arab Health is the largest healthcare event in the Middle East, held at the Dubai International Convention & Exhibition Centre from January 25-28, 2016. Firalis SAS is attending Arab Health in order to explore opportunities to establish new collaborations. Firalis SAS is a privately owned life sciences company, creating novel values via biomarker discovery, development, and regulatory qualifications. The company is mainly, but not exclusively, active in the field of drug safety, cardiovascular, inflammatory, neuro-degenerative and autoimmune diseases. Firalis provides bio-analytical services and biomarker-based products to the pharmaceutical industry, to biotechnology companies, and to universities. The company owes its leading position to a unique network of clinical centers of excellence, established to conduct studies for biomarker qualifications in clinics.

  • Firalis SAS
    Firalis SAS
    4y ago

    FIRALIS at Arab Health 2016 in Dubai Arab Heath is the largest event in the Middle East, it brings together over 4’000 companies and more than 130,000 visitors from 163 countries, and exhibits the latest products, technologies, services and networking opportunities for the healthcare industry. 30 French companies are taking part in Arab Health and Medlab this year. With 1,440 m2 in exhibition space across 2 halls, 1 entirely dedicated to laboratory equipment and diagnostics, one-third of them are participating for the first time, exhibiting the latest in products, diagnostics, consumables and equipment for health-care establishments, waste treatment, hospital supplies and in-home care.

  • Firalis SAS
    Firalis SAS
    4y ago

    FIRALIS WILL LEAD BIOMARKER ACTIVITIES IN THE « FIGHT-HF » PROJECT on HEART FAILURE Part of the call for projects "University-Hospital Research" (RHU) of Investments for the Future (Investissements d'Avenir), "FIGHT-HF", an innovative collaborative and multidisciplinary project aiming to combat heart failure, will be funded with € 9 million for 5 years. Based on criteria of scientific quality and innovation for Biomarker R&D, FIRALIS SAS has been selected to be a partner of choice for the « FIGHT-HF » project. See more at : http://www.grand-est.inserm.fr/actualites/c-est-parti-pour-combattre-l-insuffisance-cardiaque-avec-fight-hf

  • Firalis SAS
    Firalis SAS
    4y ago
    The EU-funded (EUROSTAR) MiPROG program has been launched on 4th of December 2015 by Firalis Group in collaboration with the Luxemburg Institute of Health (LIH), Lifesequencing S.L. (Valencia, Spain), and the Medical School of Hannover (MHH) (Hannover, Germany). In the frame of this €1.8 million research program, the consortium will develop an innovative diagnostic miRNA-based test for heart failure (HF) development after acute myocardial infarction (AMI).

Join Viadeo and check out the latest job offers and news from companies that interest you.

Sign up for free